Form 4: Director Brian G. Cartwright Receives Healthpeak Stock

Sentiment:

Director Equity Grant


Director Brian G. Cartwright acquired 9,744 restricted stock units in Healthpeak Properties, Inc. on May 6, 2026.

Summary

  • Director Brian G. Cartwright was granted 9,744 restricted stock units (RSUs) of Healthpeak Properties, Inc. common stock.
  • The transaction occurred on May 6, 2026, at a price of $0 per share.
  • Following this transaction, the director's total beneficial ownership increased to 83,490 shares.
  • The RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or the company's next annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in nature.

Positives

  • Increased equity alignment between the director and shareholders.

Negatives

  • None identified.

Risks

  • None identified.

Future Outlook

The restricted stock units are set to vest on the earlier of May 6, 2027, or the date of the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member interests with long-term shareholder value in the REIT sector.

Comparison to Industry Standards

  • The grant of restricted stock units to non-employee directors is a common practice among S&P 500 and major REIT companies to ensure board retention and alignment.
  • The vesting schedule is consistent with standard annual equity compensation cycles for public company directors.

Stakeholder Impact

  • Shareholders: Increased alignment of director interests with company performance.

Next Steps

  • Vesting of the 9,744 restricted stock units on the earlier of May 6, 2027, or the next annual meeting.

Key Dates

DateDescription
05/06/2026Date of the RSU grant transaction.
05/07/2026Date the Form 4 was filed with the SEC.

Keywords

Healthpeak Properties, DOC, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.